UK Cancer Diagnostics Market Segmentation Analysis, 2019-2023: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

This new report is based on a study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the UK cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

UK Market Overview

- Five-year test volume and sales projections.
- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
- Estimated universe of laboratories performing cancer diagnostic testing.
- Cancer statistics, etiology and recent developments in Spain.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes<
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test.

- Five-year test volume and sales forecasts for major tumor markers by market segment, including:

º  Hospitals
º  Commercial/Private Laboratories

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.
- Review of competing/complementing technologies.
- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

Contains 565 pages and 85 tables

I. Introduction
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers

2. Oncogenes

3. Polypeptide Growth Factors

4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers

B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies

D. Personal Testing
VIII. U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group

- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications

List Of Tables



Cancer Diagnostic Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests

Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis

Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: U.K., Total
Cancer Diagnostic Testing Volume and Sales
Forecasts by Market Segment
U.K., Estimated Cancer Death Rates
U.K., Laboratories Performing Cancer
Diagnostic Tests by Market Segment
U.K., Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
U.K., Commercial/Private Laboratories
Performing Cancer Diagnostic Tests
By Annual Test Volume
U.K., Total Cancer Diagnostic Testing Volume
Forecasts by Market Segment
U.K., All Market Segments Major
Cancer Diagnostic Test Volume Forecasts by Test
U.K., Hospital Laboratories Major
Cancer Diagnostic Test Volume Forecasts
By Test
U.K., Commercial/Private Laboratories
Major Cancer Diagnostic Test Volume Forecasts
U.K., Total Cancer Diagnostic Sales
Forecasts by Market Segment

U.K., All Market Segments Major
Cancer Diagnostic Sales Forecasts by Test
U.K., Hospital Laboratories Major
Cancer Diagnostic Sales Forecasts by Test

U.K., Commercial/Private Laboratories
Major Cancer Diagnostic Sales Forecasts by Test

U.K., ACTH Test Volume and Diagnostics Sales
Forecasts by Market Segment
U.K., AFP Test Volume and Diagnostics Sales
Forecasts by Market Segment
U.K., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.K., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., CA-125 Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Calcitonin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
U.K., CEA Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Chromogranin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Colon-Specific Antigen Test Volume
And Diagnostics Sales by Market
Segment
U.K., Cytokeratins Test Volume and
Diagnostics Sales Forecasts by Market
Segment

U.K., Estrogen Receptor Test Volume and
Diagnostics Sales Forecasts by Market
Segment
U.K., Ferritin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
U.K., Gastrin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., HCG Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Insulin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Lymphocyte Subtyping Test Volume and
Diagnostics Sales Forecasts by Market
Segment
U.K., NSE Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Occult Blood Test Volume and
Diagnostics Sales Forecasts by Market
Segment
U.K., Oncogenes Test Volume and
Diagnostics Sales Forecasts by Market
Segment
U.K., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., PAP Smear Test Volume and Diagnostics
Sales Forecasts by Market Segment

U.K., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., PAP Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., PSA Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., S-100 Protein Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.K., Serotonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Sialic Acid Test Volume and
Diagnostics Sales Forecasts by Market Segment
U.K., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., TDT Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecasts by Market Segment
U.K., Thyroglobulin
Test Volume and Diagnostics
Sales Forecasts by Market Segment

U.K., TPA Test Volume and Diagnostics
Sales Forecasts by Market Segment

U.K., Total Cancer Diagnostics Sales and
Market Shares Forecasts
U.K., CEA Testing Market Diagnostics
Sales by Major Supplier
U.K., PSA Testing Market Diagnostics
Sales by Major Supplier

UK Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

LeadingMarketResearch.coms new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.K. hematology and flow cytometry markets during the next

USD 4500 View Report

Europe Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests:France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive five-country report contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology

USD 17500 View Report

Asia Pacific Kidney Cancer Diagnostics and Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Kidney Cancer Diagnostics and Therapeutics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX

USD 3000 View Report

Cancer Diagnostics Market on the Verge of Explosion--Country Shares and Market Segment Forecasts for over 40 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence

This’s new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe

USD 18500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available